PTC Therapeutics to Participate at Upcoming Investor Conferences PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Wells Fargo 17th ...
Thursday, September 1, 2022 BiopharmaWatch Research 1 min read
Key Takeaway: SOUTH PLAINFIELD, N.J. , Sept. 1, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that the company will present a company overview at the following conferences:
Wells Fargo 17 th Annual Healthcare Conference Thursday, Sept. 8, at 1:55 p.m. EDT
Morgan
Price reaction · baseline $49.94 (2022-08-31 close) · hit after-hours · 2 other PTCT headline(s) in the window, move may be shared
day 0 close · peak
+3.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis
Full Press Release Details
SOUTH PLAINFIELD, N.J. , Sept. 1, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that the company will present a company overview at the following conferences:
Morgan Stanley 20 th Annual Global Healthcare Conference Monday, Sept. 12 , at 4:15 p.m. EDT
The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.